Multiple Preconditioning Paradigms Converge on Interferon Regulatory Factor-Dependent Signaling to Promote Tolerance to Ischemic Brain Injury

Ischemic tolerance can be induced by numerous preconditioning stimuli, including various Toll-like receptor (TLR) ligands. We have shown previously that systemic administration of the TLR4 ligand LPS or the TLR9 ligand unmethylated CpG oligodeoxynucleotide before transient brain ischemia in mice confers substantial protection against ischemic damage. To elucidate the molecular mechanisms of preconditioning, we compared brain genomic profiles in response to preconditioning with these TLR ligands and with preconditioning via exposure to brief ischemia. We found that exposure to the TLR ligands and brief ischemia induced genomic changes in the brain characteristic of a TLR pathway-mediated response. Interestingly, all three preconditioning stimuli resulted in a reprogrammed response to stroke injury that converged on a shared subset of 13 genes not evident in the genomic profile from brains that were subjected to stroke without prior preconditioning. Analysis of the promoter region of these shared genes showed sequences required for interferon regulatory factor (IRF)-mediated transcription. The importance of this IRF gene network was tested using mice deficient in IRF3 or IRF7. Our data show that both transcription factors are required for TLR-mediated preconditioning and neuroprotection. These studies are the first to discover a convergent mechanism of neuroprotection induced by preconditioning—one that potentially results in reprogramming of the TLR-mediated response to stroke and requires the presence of IRF3 and IRF7.

[1]  J. Kirby,et al.  Toll-like receptor interactions: tolerance of MyD88-dependent cytokines but enhancement of MyD88-independent interferon-beta production. , 2007, Immunology.

[2]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[3]  U. Dirnagl,et al.  Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use , 2009, The Lancet Neurology.

[4]  Daniel E. Zak,et al.  PAINT: a promoter analysis and interaction network generation tool for gene regulatory network identification. , 2003, Omics : a journal of integrative biology.

[5]  J. Pagano,et al.  Regulation of the Transcriptional Activity of the IRF7 Promoter by a Pathway Independent of Interferon Signaling* , 2005, Journal of Biological Chemistry.

[6]  J. Kirby,et al.  Toll‐like receptor interactions: tolerance of MyD88‐dependent cytokines but enhancement of MyD88‐independent interferon‐β production , 2007 .

[7]  R. Nitsch,et al.  Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia , 2007, Journal of Neuroimmunology.

[8]  Y. Tan,et al.  Interferon-β administration confers a beneficial outcome in a rabbit model of thromboembolic cerebral ischemia , 2002, Neuroscience Letters.

[9]  T. Taniguchi,et al.  Distinct and Essential Roles of Transcription Factors IRF-3 and IRF-7 in Response to Viruses for IFN-α/β Gene Induction , 2000 .

[10]  B. Engelhardt,et al.  Interferon-β stabilizes barrier characteristics of the blood–brain barrier in four different species in vitro , 2008, Multiple sclerosis.

[11]  C. Harrington,et al.  For Personal Use. Only Reproduce with Permission from the Lancet , 2022 .

[12]  M. Mattson,et al.  Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits , 2007, Proceedings of the National Academy of Sciences.

[13]  T. Ohtsuki,et al.  Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats , 1997, Brain Research.

[14]  A. Minagar,et al.  Interferon (IFN)-beta 1a and IFN-beta 1b block IFN-gamma-induced disintegration of endothelial junction integrity and barrier. , 2003, Endothelium : journal of endothelial cell research.

[15]  T. Taniguchi,et al.  Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. , 2000, Immunity.

[16]  S. Akira,et al.  Role for MyD88-Independent, TRIF Pathway in Lipid A/TLR4-Induced Endotoxin Tolerance1 , 2007, The Journal of Immunology.

[17]  E. Lucchinetti,et al.  Ischemic but not pharmacological preconditioning elicits a gene expression profile similar to unprotected myocardium. , 2004, Physiological genomics.

[18]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[19]  T. Sobrino,et al.  Toll-like receptors 2 and 4 in ischemic stroke: Outcome and therapeutic values , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[20]  S. L. Stevens,et al.  Inflammation and the Emerging Role of the Toll-Like Receptor System in Acute Brain Ischemia , 2009, Stroke.

[21]  Kiyoko F. Aoki-Kinoshita,et al.  From genomics to chemical genomics: new developments in KEGG , 2005, Nucleic Acids Res..

[22]  Charles H. Lin,et al.  Mechanism for transcriptional synergy between interferon regulatory factor (IRF)-3 and IRF-7 in activation of the interferon-beta gene promoter. , 2004, European journal of biochemistry.

[23]  Susumu Goto,et al.  KEGG for representation and analysis of molecular networks involving diseases and drugs , 2009, Nucleic Acids Res..

[24]  C. Harrington,et al.  Systemic Lipopolysaccharide Protects the Brain from Ischemic Injury by Reprogramming the Response of the Brain to Stroke: A Critical Role for IRF3 , 2009, The Journal of Neuroscience.

[25]  J. S. King,et al.  Preconditioning Reprograms the Response to Ischemic Injury and Primes the Emergence of Unique Endogenous Neuroprotective Phenotypes: A Speculative Synthesis , 2007, Stroke.

[26]  R. Simon,et al.  Toll-Like Receptor 9: A New Target of Ischemic Preconditioning in the Brain , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[27]  E. Lucchinetti,et al.  Trigger-dependent Gene Expression Profiles in Cardiac Preconditioning: Evidence for Distinct Genetic Programs in Ischemic and Anesthetic Preconditioning , 2004, Anesthesiology.

[28]  M. Schwaninger,et al.  NF-κB signaling in cerebral ischemia , 2009, Neuroscience.

[29]  Jie Cui,et al.  Reduced cerebral ischemia-reperfusion injury in Toll-like receptor 4 deficient mice. , 2007, Biochemical and biophysical research communications.

[30]  K. Nicolay,et al.  Interferon-Beta Blocks Infiltration of Inflammatory Cells and Reduces Infarct Volume after Ischemic Stroke in the Rat , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[31]  D. Weissman,et al.  Inhibition of Toll-like Receptor and Cytokine Signaling—A Unifying Theme in Ischemic Tolerance , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[32]  J. Kalbfleisch,et al.  Preconditioning with a TLR2 specific ligand increases resistance to cerebral ischemia/reperfusion injury , 2008, Journal of Neuroimmunology.

[33]  C. Buss,et al.  Essential Role of Mitochondrial Antiviral Signaling, IFN Regulatory Factor (IRF)3, and IRF7 in Chlamydophila pneumoniae-Mediated IFN-β Response and Control of Bacterial Replication in Human Endothelial Cells , 2010, The Journal of Immunology.

[34]  P. Pitha,et al.  Analysis of functional domains of interferon regulatory factor 7 and its association with IRF-3. , 2001, Virology.

[35]  K. Honda,et al.  Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[36]  R A Swanson,et al.  A Semiautomated Method for Measuring Brain Infarct Volume , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[37]  Y. Benjamini,et al.  More powerful procedures for multiple significance testing. , 1990, Statistics in medicine.

[38]  S. L. Stevens,et al.  The use of flow cytometry to evaluate temporal changes in inflammatory cells following focal cerebral ischemia in mice , 2002, Brain Research.

[39]  K. Nicolay,et al.  Interferon-Beta Prevents Cytokine-Induced Neutrophil Infiltration and Attenuates Blood–Brain Barrier Disruption , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[40]  M. Minami,et al.  Endotoxin Preconditioning Prevents Cellular Inflammatory Response During Ischemic Neuroprotection in Mice , 2004, Stroke.

[41]  T. Taniguchi,et al.  Involvement of the IRF family transcription factor IRF‐3 in virus‐induced activation of the IFN‐β gene , 1998, FEBS letters.

[42]  M. Minami,et al.  Endotoxin Preconditioning Protects against the Cytotoxic Effects of TNFα after Stroke: A Novel Role for TNFα in LPS-Ischemic Tolerance , 2007 .

[43]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[44]  M. Stenzel-Poore,et al.  Lipopolysaccharide preconditioning induces robust protection against brain injury resulting from deep hypothermic circulatory arrest. , 2007, The Journal of thoracic and cardiovascular surgery.

[45]  O. Hurtado,et al.  Toll‐like receptor 4 is involved in neuroprotection afforded by ischemic preconditioning , 2009, Journal of neurochemistry.